A novel approach to simultaneously scan genes at fragile sites

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Willem, Pascale ^a   Brown, Jacqueline ^a   Schouten, Jan ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b MRC HOLLAND   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN; OXIDOREDUCTASE;

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; CARCINOGENESIS; CHROMOSOME 3; CHROMOSOME FRAGILE SITE; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXON; GENE AMPLIFICATION; GENE DELETION; GENE DUPLICATION; GENE EXPRESSION; HEMIZYGOSITY; HETEROZYGOSITY LOSS; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTH AFRICA; VALIDATION PROCESS;

ACID ANHYDRIDE HYDROLASES; CARCINOMA; CHROMOSOME DELETION; CHROMOSOME FRAGILE SITES; CHROMOSOMES, HUMAN, PAIR 16; CHROMOSOMES, HUMAN, PAIR 3; DNA PROBES; ESOPHAGEAL NEOPLASMS; FEMALE; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM PROTEINS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; OXIDOREDUCTASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 33748918143     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-205     Document Type: Article

References (63)

1. Corbin S, Neilly ME, Espinosa R, Davis EM, McKeithan TW, Le Beau MM: Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Cancer Res 2002, 62(12):3477-3484.
2. Bednarek AK, Laflin KJ, Daniel RL, Liao Q, Hawkins KA, Aldaz CM: WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. Cancer Res 2000, 60(8):2140-2145.
3. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K: The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996, 84(4):587-597.
4. Matsuyama A, Croce CM, Huebner K: Common fragile genes. Eur J Histochem 2004, 48(1):29-36.
5. Huebner K, Croce CM: FRA3B and other common fragile sites: the weakest links. Nat Rev Cancer 2001, 1(3):214-221.
6. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM: Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSFIA, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003, 63(13):3724-3728.
7. Kitamura A, Yashima K, Okamoto E, Andachi H, Hosoda A, Kishimoto Y, Shiota G, Ito H, Kaibara N, Kawasaki H: Reduced Fhit expression occurs in the early stage of esophageal tumorigenesis: no correlation with p53 expression and apoptosis. Oncology 2001, 61(3):205-211.
8. Mori M, Mimori K, Shiraishi T, Alder H, Inoue H, Tanaka Y, Sugimachi K, Huebner K, Croce CM: Altered expression of Fhit in carcinoma and precarcinomatous lesions of the esophagus. Cancer Res 2000, 60(5):1177-1182.
9. Noguchi T, Takeno S, Kimura Y, Uchida Y, Daa T, Yokoyama S, Gabbert HE, Mueller W: FHIT expression and hypermethylation in esophageal squamous cell carcinoma. Int J Mol Med 2003, 11(4):441-447.
10. National Cancer Registry of South Africa: Johannesburg, National Cancer Registry of South Africa, National Health Laboratory; 2004.
11. Pacella-Norman R, Urban MI, Sitas F, Carrara H, Sur R, Hale M, Ruff P, Patel M, Newton R, Bull D, Beral V: Risk factors for oesophageal, lung, oral and laryngeal cancers in black South Africans. Br J Cancer 2002, 86(11):1751-1756.
12. Marasas WF, van Rensburg SJ, Mirocha CJ: Incidence of Fusarium species and the mycotoxins, deoxynivalenol and zearalenone, in corn produced in esophageal cancer areas in Transkei. J Agric Food Chem 1979, 27(5):1108-1112.
13. Dandara C, Ballo R, Parker MI: CYP3A5 genotypes and risk of oesophageal cancer in two South African populations. Cancer Lett 2005, 225(2):275-282.
14. Isaacson C: The change of the staple diet of black South Africans from sorghum to maize (corn) is the cause of the epidemic of squamous carcinoma of the oesophagus. Med Hypotheses 2005, 64(3):658-660.
15. Matsha T, Erasmus R, Kafuko AB, Mugwanya D, Stepien A, Parker MI: Human papillomavirus associated with oesophageal cancer. J Clin Pathol 2002, 55(8):587-590.
16. Stein CK, Glover TW, Palmer JL, Glisson BS: Direct correlation between FRA3B expression and cigarette smoking. Genes Chromosomes Cancer 2002, 34(3):333-340.
17. Thorland EC, Myers SL, Gostout BS, Smith DI: Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 2003, 22(8):1225-1237.
18. Stevens VL, Tang J: Fumonisin BI-induced sphingolipid depletion inhibits vitamin uptake via the glycosylphosphatidylinositol-anchored folate receptor. J Biol Chem 1997, 272(29):18020-18025.
19. Capaccio P, Ottaviani F, Cuccarini V, Cenzuales S, Cesana BM, Pignataro L: Association between methylenetetrahydrofolate reductase polymorphisms, alcohol intake and oropharyngolaryngeal carcinoma in northern Italy. J Laryngol Otol 2005, 119(5):371-376.
20. Yokoyama T, Saito K, Lwin H, Yoshiike N, Yamamoto A, Matsushita Y, Date C, Tanaka H: Epidemiological evidence that acetaldehyde plays a significant role in the development of decreased serum folate concentration and elevated mean corpuscular volume in alcohol drinkers. Alcohol Clin Exp Res 2005, 29(4):622-630.
21. Knasmuller S, Bresgen N, Kassie F, Mersch-Sundermann V, Gelderblom W, Zohrer E, Eckl PM: Genotoxic effects of three Fusarium mycotoxins, fumonisin B1, moniliformin and vomitoxin in bacteria and in primary cultures of rat hepatocytes. Mutat Res 1997, 391(1-2):39-48.
22. Lerda D, Biaggi Bistoni M, Peralta N, Ychari S, Vazquez M, Bosio G: Fumonisins in foods from Cordoba (Argentina), presence and genotoxicity. Food Chem Toxicol 2005, 43(5):691-698.
23. Xiao YP, Wu DY, Xu L, Xin Y: Loss of heterozygosity and microsatellite instabilities of fragile histidine triad gene in gastric carcinoma. World J Gastroenterol 2006, 12(23):3766-3769.
24. Liu H, Peng ZL, Wang H, Liu SL, Zhang CS, Tang QP, He B: [Study on the relationship between LOH and MI of FHIT gene and the development of cervical carcinoma]. Sichuan Da Xue Xue Bao Yi Xue Ban 2005, 36(4):506-509.
25. Boldog F, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H, Drabkin HA: Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Hum Mol Genet 1997, 6(2):193-203.
26. Chen PM, Yang MH, Hsiao LT, Yu IT, Chu CJ, Chao TC, Yen CC, Wang WS, Chiou TJ, Liu JH: Decreased FHIT protein expression correlates with a worse prognosis in patients with diffuse large B-cell lymphoma. Oncol Rep 2004, 11(2):349-356.
27. Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, McCue P, Huebner K: The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma. Cancer 2004, 100(8):1605-1614.
28. Guerin LA, Hoffman HT, Zimmerman MB, Robinson RA: Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma. Arch Pathol Lab Med 2006, 130(2):158-164.
29. Sarli L, Bottarelli L, Azzoni C, Campanini N, Di Cola G, Bader G, Iusco D, Salvemini C, Caruso G, Donadei E, Pizzi S, D'Adda T, Renato C, Roncoroni L, Bordi C: Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer. Eur J Cancer 2004, 40(10):1581-1588.
30. Iliopoulos D, Guler G, Han SY, Johnston D, Druck T, McCorkell KA, Palazzo J, McCue PA, Baffa R, Huebner K: Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer. Oncogene 2005, 24(9):1625-1633.
31. Liu FX, Huang XP, Zhao CX, Xu X, Han YL, Cai Y, Wu RL, Wu M, Zhan QM, Wang MR: [Allelic loss and down-regulation of FHIT gene expression in esophageal squamous cell carcinoma]. Ai Zheng 2004, 23(9):992-998.
32. Druck T, Hadaczek P, Fu TB, Ohta M, Siprashvili Z, Baffa R, Negrini M, Kastury K, Veronese ML, Rosen D, Rothstein J, McCue P, Cotticelli MG, Inoue H, Croce CM, Huebner K: Structure and expression of the human FHIT gene in normal and tumor cells. Cancer Res 1997, 57(3):504-512.
33. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G: Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002, 30(12):e57.
34. Bey E, Alexander J, Whitcutt JM, Hunt JA, Gear JH: Carcinoma of the esophagus in Africans: establishment of a continuously growing cell line from a tumor specimen. In Vitro 1976, 12(2):107-114.
35. Veale RB, Thornley A: Increased single class low-affinity EGF receptors expressed by human oesophageal squamous cell carcinoma lines. In South African Journal of Science Volume 85. South Africa; 1989:375-379.
36. Fang JM, Arlt MF, Burgess AC, Dagenais SL, Beer DG, Glover TW: Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma. Genes Chromosomes Cancer 2001, 30(3):292-298.
37. Buffart TE, Coffa J, Hermsen MA, Carvalho B, van der Sijp JR, Ylstra B, Pals G, Schouten JP, Meijer GA: DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cell Oncol 2005, 27(1):57-65.
38. Postma C, Hermsen MA, Coffa J, Baak JP, Mueller JD, Mueller E, Bethke B, Schouten JP, Stolte M, Meijer GA: Chromosomal instability in flat adenomas and carcinomas of the colon. J Pathol 2005, 205(4):514-521.
39. Vorstman JA, Jalali GR, Rappaport EF, Hacker AM, Scott C, Emanuel BS: MLPA: a rapid, reliable, and sensitive method for detection and analysis of abnormalities of 22q. Hum Mutat 2006.
40. Lee YC, Wu CT, Shih JY, Jou YS, Chang YL: Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers. Br J Cancer 2004, 90(12):2378-2383.
41. Cheung AL, Si HX, Wang LD, An JY, Tsao SW: Loss of heterozygosity analyses of esophageal squamous cell carcinoma and precursor lesions from a high incidence area in China. Cancer Lett 2005.
42. Santos SC, Cavalli LR, Cavalli IJ, Lima RS, Haddad BR, Ribeiro EM: Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil. J Clin Pathol 2004, 57(4):374-377.
43. Mimori K, Druck T, Inoue H, Alder H, Berk L, Mori M, Huebner K, Croce CM: Cancer-specific chromosome alterations in the constitutive fragile region FRA3B. Proc Natl Acad Sci U S A 1999, 96(13):7456-7461.
44. Chen YJ, Chen PH, Lee MD, Chang JG: Aberrant FHIT transcripts in cancerous and corresponding non-cancerous lesions of the digestive tract. Int J Cancer 1997, 72(6):955-958.
45. Chu TY, Shen CY, Chiou YS, Lu JJ, Perng CL, Yu MS, Liu HS: HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA. Int J Cancer 1998, 75(2):199-204.
46. Matthews CP, Shera K, Kiviat N, McDougall JK: Expression of truncated FHIT transcripts in cervical cancers and in normal human cells. Oncogene 2001, 20(34):4665-4675.
47. Zanesi N, Fidanza V, Fong LY, Mancini R, Druck T, Valtieri M, Rudiger T, McCue PA, Croce CM, Huebner K: The tumor spectrum in FHIT-deficient mice. Proc Natl Acad Sci U S A 2001, 98(18):10250-10255.
48. Sard L, Accornero P, Tornielli S, Delia D, Bunone G, Campiglio M, Colombo MP, Gramegna M, Croce CM, Pierotti MA, Sozzi G: The tumor-suppressor gene FHIT is involved in the regulation of apoptosis and in cell cycle control. Proc Natl Acad Sci U S A 1999, 96(15):8489-8492.
49. Tanimoto K, Hayashi S, Tsuchiya E, Tokuchi Y, Kobayashi Y, Yoshiga K, Okui T, Kobayashi M, Ichikawa T: Abnormalities of the FHIT gene in human oral carcinogenesis. Br J Cancer 2000, 82(4):838-843.
50. van Heerden WF, Swart TJ, Robson B, Smith TL, Engelbrecht S, van Heerden MB, van Rensburg EJ, Huebner K: FHIT RNA and protein expression in oral squamous cell carcinomas. Anticancer Res 2001, 21(4A):2425-2428.
51. van Heerden WF, Swart TJ, van Heerden MB, Pekarsky Y, Sutherland R, Huebner K: Fhit protein expression in oral epithelium: immunohistochemical evaluation of three antisera. Anticancer Res 2001, 21(4A):2419-2423.
52. Ishii H, Vecchione A, Furukawa Y, Sutheesophon K, Han SY, Druck T, Kuroki T, Trapasso F, Nishimura M, Saito Y, Ozawa K, Croce CM, Huebner K, Furukawa Y: Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Mol Cancer Res 2003, 1(13):940-947.
53. Ishii H, Furukawa Y: Alterations of common chromosome fragile sites in hematopoietic malignancies. Int J Hematol 2004, 79(3):238-242.
54. Guler G, Uner A, Guler N, Han SY, Iliopoulos D, McCue P, Huebner K: Concordant loss of fragile gene expression early in breast cancer development. Pathol Int 2005, 55(8):471-478.
55. Glover TW, Stein CK: Induction of sister chromatid exchanges at common fragile sites. Am J Hum Genet 1987, 41(5):882-890.
56. Kuroki T, Trapasso F, Shiraishi T, Alder H, Mimori K, Mori M, Croce CM: Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res 2002, 62(8):2258-2260.
57. Kuroki T, Yendamuri S, Trapasso F, Matsuyama A, Aqeilan RI, Alder H, Rattan S, Cesari R, Nolli ML, Williams NN, Mori M, Kanematsu T, Croce CM: The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res 2004, 10(7):2459-2465.
58. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, Volinia S, Croce CM, Morrison CD, Klein RD, Huebner K: A Role for the WWOX Gene in Prostate Cancer. Cancer Res 2006, 66(13):6477-6481.
59. Arun B, Kilic G, Yen C, Foster B, Yardley DA, Gaynor R, Ashfaq R: Loss of FHIT expression in breast cancer is correlated with poor prognostic markers. Cancer Epidemiol Biomarkers Prev 2005, 14(7):1681-1685.
60. Aqeilan RI, Kuroki T, Pekarsky Y, Albagha O, Trapasso F, Baffa R, Huebner K, Edmonds P, Croce CM: Loss of WWOX expression in gastric carcinoma. Clin Cancer Res 2004, 10(9):3053-3058.
61. Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C, Orntoft T, Lukas J, Bartek J: DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 2005, 434(7035):864-870.
62. Gorgoulis VG, Vassiliou LV, Karakaidos P, Zacharatos P, Kotsinas A, Liloglou T, Venere M, Ditullio RAJ, Kastrinakis NG, Levy B, Kletsas D, Yoneta A, Herlyn M, Kittas C, Halazonetis TD: Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 2005, 434(7035):907-913.
63. Casper AM, Nghiem P, Arlt MF, Glover TW: ATR regulates fragile site stability. Cell 2002, 111(6):779-789.